Trademark Overview
On Thursday, January 25, 2024, a trademark application was filed for ENVOYA with the United States Patent and Trademark Office. The USPTO has given the ENVOYA trademark a serial number of 98376231. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 28, 2024. This trademark is owned by Envoya Inc.. The ENVOYA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Gene therapy products; gene therapy products, namely polymer-based nanoparticles; nucleic acid-containing products, namely RNA and DNA; gene therapy products for the treatment of cancer, metabolic diseases or disorders, neurodegenerative diseases or disorders, cardiovascular diseases or disorders, infectious diseases, or inflammatory diseases or disorders; nanoparticle products for medical or veterinary purposes; microparticle products for medical or veterinary purposes; nanoparticles for medical or veterinary purposes; microparticles for medical or veterinary purposes; nanoparticles to encapsulate a payload for medical or veterinary purposes; microparticles to encapsulate a payload for medical or veterinary purposes; nanoparticles designed to encapsulate nucleic acids, proteins, small molecules for medical or veterinary purposes; microparticles designed to encapsulate nucleic acids, proteins, small molecules for medical or veterinary purposes; nanoparticles to encapsulate nucleic acid...
Pharmaceutical research and development; research and development services; gene therapy research and development services; research and development collaboration services to enhance the delivery of RNA and DNA therapeutics to patients; research and development collaboration services in the field of pharmaceuticals; research and development collaboration services in the field of nanoparticles and microparticles; research and development collaboration services in the field of nucleic acid-containing particles; research and development collaboration services in the field of nucleic acids, proteins, and small molecules delivery; encapsulating nucleic acids, namely RNA and DNA, in tailored nanoparticles for targeted delivery; analyzing nanoparticle characteristics; analyzing microparticle characteristics; research and development collaboration services in the field of pharmaceutical preparations for the treatment of disease or disorders; research and development collaboration services in t...
